Conformal re-irradiation of recurrent and new primary head-and-neck cancer (Q34266157)

1 August 2017

title

Conformal re-irradiation of recurrent and new primary head-and-neck cancer (English)

1 reference

1 August 2017

Dawson LA

1

1 reference

1 August 2017

Myers LL

2

1 reference

1 August 2017

Bradford CR

3

1 reference

1 August 2017

Chepeha DB

4

1 reference

1 August 2017

Hogikyan ND

5

1 reference

1 August 2017

Teknos TN

6

1 reference

1 August 2017

Terrell JE

7

1 reference

1 August 2017

Wolf GT

8

1 reference

1 August 2017

Eisbruch A

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

International Journal of Radiation Oncology Biology Physics

1 August 2017

published in

1 reference

1 August 2017

volume

50

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

377-385

1 reference

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Re-irradiation of laryngeal carcinoma--techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

High-dose reirradiation of head and neck cancer with curative intent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Treatment of Locally Recurrent Carcinoma of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Reirradiation for recurrent nasopharyngeal carcinoma: Factors affecting the therapeutic ratio and ways for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Interstitial re-irradiation for recurrent and/or persistent head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Radiation Therapy of Recurrent Nasopharyngeal Carcinoma: Report on 219 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Reirradiation of recurrent tumors in the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Reirradiation of recurrent head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Clinical dose-response curves of human malignant epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Concurrent chemoradiotherapy for salvage in relapsed squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy greater than or equal to 4 cm diameter in 23 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Persistent carcinoma of the oropharynx and oral cavity re-treated by after-loading interstitial 192Ir implant

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Treatment selection factors for stereotactic radiosurgery of intracranial metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

Application of stereotactic radiosurgery to the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901456-0

7 January 2021

10.1016/S0360-3016(01)01456-0

Identifiers

DOI

1 reference

1 August 2017

1 reference